高视医疗预期2024财年利润减少约48.8%至53.6%

格隆汇2025-03-07

格隆汇3月7日丨高视医疗(02407.HK)发布公告，相比截至2023年12月31日止财政年度录得利润净额约人民币172.9百万元，预期集团于2024财年录得利润净额约人民币80.2百万元至人民币88.6百万元，减少约48.8%至53.6%。影响利润净额的主要因素情况如下：1. 尽管面对经济环境及竞争压力的影响，集团仍积极拓展其销售领域，并依托成熟的销售渠道、完善的售前支持及售后服务、优秀的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2517316489?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-07 19:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2517316489","market":"hk","top_or_hot":-1,"title":"高视医疗预期2024财年利润减少约48.8%至53.6%","media":"格隆汇","content":"<div>\n<p>格隆汇3月7日丨高视医疗(02407.HK)发布公告，相比截至2023年12月31日止财政年度录得利润净额约人民币172.9百万元，预期集团于2024财年录得利润净额约人民币80.2百万元至人民币88.6百万元，减少约48.8%至53.6%。影响利润净额的主要因素情况如下：1. 尽管面对经济环境及竞争压力的影响，集团仍积极拓展其销售领域，并依托成熟的销售渠道、完善的售前支持及售后服务、优秀的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307194723abed08be&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>高视医疗预期2024财年利润减少约48.8%至53.6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n高视医疗预期2024财年利润减少约48.8%至53.6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-07 19:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307194723abed08be&s=b><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇3月7日丨高视医疗(02407.HK)发布公告，相比截至2023年12月31日止财政年度录得利润净额约人民币172.9百万元，预期集团于2024财年录得利润净额约人民币80.2百万元至人民币88.6百万元，减少约48.8%至53.6%。影响利润净额的主要因素情况如下：1. 尽管面对经济环境及竞争压力的影响，集团仍积极拓展其销售领域，并依托成熟的销售渠道、完善的售前支持及售后服务、优秀的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307194723abed08be&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02407","symbol_name":"高视医疗","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307194723abed08be&s=b","article_id":"2517316489","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307194723abed08be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2517316489","pubTimestamp":1741348043,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇3月7日丨高视医疗发布公告，相比截至2023年12月31日止财政年度录得利润净额约人民币172.9百万元，预期集团于2024财年录得利润净额约人民币80.2百万元至人民币88.6百万元，减少约48.8%至53.6%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02407":"高视医疗","BK1100":"医疗保健设备"},"translate_title":"High Vision Medical expects fiscal 2024 profit to decrease by approximately 48.8% to 53.6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02407":1},"content_text":"格隆汇3月7日丨高视医疗(02407.HK)发布公告，相比截至2023年12月31日止财政年度录得利润净额约人民币172.9百万元，预期集团于2024财年录得利润净额约人民币80.2百万元至人民币88.6百万元，减少约48.8%至53.6%。影响利润净额的主要因素情况如下：1. 尽管面对经济环境及竞争压力的影响，集团仍积极拓展其销售领域，并依托成熟的销售渠道、完善的售前支持及售后服务、优秀的市场推广及产品组合策略，2024年下半年收入较2024年上半年收入实现显著提升，2024财年收入相较2023财年保持基本稳定。然而受汇率波动、人工晶体国采政策执行等因素的影响，集团的综合毛利率降低，使得毛利润减少。2. 应市场需求变化及竞争压力，集团计划调整电生理产品及视光产品战略方向，受此调整，经谨慎考虑公司附属公司Roland Consult Stasche &Finger GmbH和宁波高斯医疗科技有限公司近年来的经营状况并结合管理层对未来市场的预期，集团预期会在2024财年对相关现金产生单元录得的商誉计提减值拨备，估计金额约人民币22.1百万元至人民币24.5百万元。上述商誉减值拨备的短期影响并不会对集团未来的运营及现金流产生任何重大不利影响。3. 集团紧随国家战略部署，持续加大研究及开发项目投入，加强自主创新能力建设，以确保中长期发展竞争力，于2024财年研发开支较2023财年显著增加约人民币21.6百万元至人民币29.4百万元，且研发支出占自有产品收入百分比持续增加。4. 2024财年欧元持续位于高位，且美元走强，2024财年内人民币兑外币的汇率变动导致出现汇兑损失约人民币5.4百万元至人民币6.0百万元，而2023财年为汇兑收益约人民币15.6百万元。展望未来，公司对行业前景依然充满信心，并将持续优化产品结构，加快产研工作步伐，深化销售渠道拓展，不断提升运营效率，努力实现业绩的稳健增长与盈利水平的提升。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2517316489","isCrawlerRequest":true}